| http://www.w3.org/ns/prov#value | - The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a multi-center, randomized trial aimed at determining disease-specific mortality outcomes.?? The goal relative to prostate cancer was to determine if a reduction in prostate cancer mortality would occur through screening via PSA and DRE.?? A recent manuscript summary reported data 13 years in follow-up after the trial.
|
